Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Spiro Indolone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111057062A details a green phosphotungstic acid catalyzed route for spiro indolone, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109776381B details a green aqueous synthesis for spiro indolones using quaternary ammonium iodide, offering significant cost reduction and supply chain reliability.
Patent CN105693719A details iron-catalyzed synthesis of 3,3-spiro indolones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel asymmetric oxidative coupling method for chiral spiro indolones using cinchona catalysts. High yield, mild conditions, scalable manufacturing for pharmaceutical intermediates.
Novel one-step synthesis for spiro pyrrole-indolone derivatives. Enhances stereochemical control and scalability for reliable pharmaceutical intermediates supply chains.
Patent CN113980028A reveals a mild organocatalytic route for chiral spiro indolones. Discover cost-effective manufacturing and high stereoselectivity for API intermediates.
Patent CN113980028A details a novel organocatalytic route for chiral spiro indolones. This method offers mild conditions, high stereoselectivity, and scalable manufacturing for pharmaceutical intermediates.
Patent CN113980028A details a mild, scalable method for chiral spiro indolones using cinchona alkaloid catalysts, offering high stereoselectivity for pharmaceutical intermediates.
Discover a novel method for preparing chiral spiro indolone compounds using cinchona alkaloid catalysts. High yield, mild conditions, and scalable pharma intermediate production.
Patent CN112250614B details a metal-free, one-pot synthesis of 3-spiro-tricyclic indolones using NBS, offering significant cost reduction and scalability for pharmaceutical manufacturing.
This patent details a novel one-step synthesis route for spiro pyrroloindolone derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN115093413B details a mild hypervalent iodine-mediated synthesis of spiroindole alkaloids, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN113980028A reveals a mild oxidative coupling method for chiral spiro indolones, offering scalable routes for reliable pharmaceutical intermediate suppliers.